Botulinum toxin in focus: evolution, pharmacology, and its expanding clinical impact
Despite the practical challenges of prescribing BoNT A, it is generally regarded as an effective therapy. Its use requires careful risk vs benefit evaluation and strict adherence to guidelines to reduce adverse outcomes. Non-response and immunogenicity remain important barriers, although ongoing research and engineered toxins point toward a future with more precision-based applications.
Authors
- Mehwash Nadeem (ORCID: https://orcid.org/0000-0002-1427-8850)
- Pragnitha Chitteti (ORCID: https://orcid.org/0000-0001-6682-7092)
- Hafiza Ayesha Khan
Institutions
- James Cook University Hospital (GB)
- Northern Health and Social Care Trust (GB)
- Newcastle University (GB)
Publication Details
- Journal
- Expert Review of Clinical Pharmacology
- Published
- 2025-11-21
- DOI
- https://doi.org/10.1080/17512433.2025.2594489
- Citations
- 1
- Primary Topic
- Botulinum Toxin and Related Neurological Disorders
- Type
- article
- Field-Weighted Citation Impact
- 1.39